Baldness Treatment Risks: ANSM Alerts – CNEWS
- Paris, France - A widely-used drug for male pattern baldness, finasteride, is facing increased scrutiny over potential side effects, including persistent sexual dysfunction and, more recently, reports of...
- What: Increased scrutiny of finasteride, a drug used to treat male pattern baldness, due to reported side effects including sexual dysfunction and suicidal thoughts.
- The French National Agency for the Safety of Medicines and Health Products (ANSM) recently issued an alert regarding the risks associated with finasteride.
Finasteride: Risks, Regulation & Patient Safety Concerns Mount
Paris, France - A widely-used drug for male pattern baldness, finasteride, is facing increased scrutiny over potential side effects, including persistent sexual dysfunction and, more recently, reports of suicidal ideation. Regulatory bodies in France and beyond are responding with stricter warnings and proposed measures to improve patient safety. This comes after decades of use with concerns largely dismissed or downplayed.
The French National Agency for the Safety of Medicines and Health Products (ANSM) recently issued an alert regarding the risks associated with finasteride. This follows similar concerns raised by medical professionals and patient advocacy groups for years. While effective in slowing hair loss, the drug’s potential for adverse effects is now being taken more seriously. The concerns aren’t new, but the level of official acknowledgement and proposed action is.
The Core Concerns: Beyond Hair Loss
Finasteride works by blocking the conversion of testosterone to dihydrotestosterone (DHT),a hormone linked to hair loss. However,DHT also plays a role in other bodily functions,and inhibiting its production can lead to a range of side effects.
Here’s a breakdown of the key issues:
* Sexual Dysfunction: This is the most commonly reported side effect, including decreased libido, erectile dysfunction, and ejaculation disorders. Critically, some men report these symptoms persist even after stopping the medication - a condition known as Post-Finasteride Syndrome (PFS).
* Psychological Effects: Increasingly, reports link finasteride to depression, anxiety, and, most alarmingly, suicidal ideation. A recent article in JIM.fr highlights that the recognition of this risk is “twenty years late.”
* Other Adverse Effects: Less common, but reported, side effects include gynecomastia (breast enlargement), testicular pain, and cognitive impairment.
Regulatory Response & Patient Safety Measures
The ANSM’s recent alert mandates that a patient data card be included in each box of 1mg finasteride, detailing the potential risks. This is a significant step towards ensuring patients are fully informed before starting treatment.
“The belated acknowledgement of the potential for serious and persistent side effects from finasteride is a crucial progress. For years, patient reports were often dismissed as anecdotal or psychological. The ANSM’s action, and the growing body of medical literature, validates those experiences.The inclusion of a patient card is a good start, but ongoing pharmacovigilance and further research into the long-term effects of finasteride are essential.The potential for suicidal ideation is particularly concerning and requires immediate attention.”
– drjenniferchen
Here’s a table summarizing the regulatory actions and proposed changes:
| Country | Regulatory Body | Action Taken/Proposed |
|---|---|---|
| France | ANSM | Mandatory patient information card in each 1mg finasteride box. Increased pharmacovigilance. |
| (Potential) | EMA (European Medicines Agency) | Review of finasteride safety profile based on french findings. Potential for wider EU-level action. |
| (Ongoing) |
Keep reading |